|
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Splicing factor mutations in myelodysplasia
|
Oct 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
The Non-transplant Treatment of Myelodysplastic Syndromes-What's on the Horizon?
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Predictors of Hemoglobin Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria
|
Oct 2012
|
Eur J Haematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses
|
Oct 2012
|
Can Oncol Nurs J
|
myelodysplastic syndromes (MDS)
|
|
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis
|
Sep 2012
|
Tumour Biol
|
myelodysplastic syndromes (MDS)
|
|
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
|
Sep 2012
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
